Biontech

 

BIONTECH IMFS is a CDMO specialized in the industrialization of cell and gene therapy products (viral vectors, cells and ivt mRNA). For 20 years, BIONTECH IMFS has been developing and manufacturing retroviral vectors and cellular products for clinical supply in a variety of monogenetic diseases and different cancer indications.

Based on extensive expertise in scientific, technical and regulatory prerequisites, we develop and manufacture your products in a safe and cost-efficient way in our state-of-the-art GMP facility.

We offer a complete service spectrum from process development through clinical trial to in-market supply. All services are fully integrated and supervised by our QA department, ensuring efficient and compliant manufacturing.

www.biontech-imfs.de